Autor segons l'article: Aristei C; Kaidar-Person O; Boersma L; Leonardi MC; Offersen B; Franco P; Arenas M; Bourgier C; Pfeffer R; Kouloulias V; Bölükbaşı Y; Meattini I; Coles C; Luis AM; Masiello V; Palumbo I; Morganti AG; Perrucci E; Tombolini V; Krengli M; Marazzi F; Trigo L; Borghesi S; Ciabattoni A; Ratoša I; Valentini V; Poortmans P
Departament: Ciències Mèdiques Bàsiques
Autor/s de la URV: Arenas Prat, Meritxell
Paraules clau: Re-irradiation in relapsed patients Radiation therapy Immunotherapy Combined modality treatment Breast cancer
Resum: The present white paper, referring to the 4th Assisi Think Tank Meeting on breast cancer, reviews state-of-the-art data, on-going studies and research proposals. < 70% agreement in an online questionnaire identified the following clinical challenges: 1: Nodal RT in patients who have a) 1-2 positive sentinel nodes without ALND (axillary lymph node dissection); b) cN1 disease transformed into ypN0 by primary systemic therapy and c) 1-3 positive nodes after mastectomy and ALND. 2. The optimal combination of RT and immunotherapy (IT), patient selection, IT-RT timing, and RT optimal dose, fractionation and target volume. Most experts agreed that RT- IT combination does not enhance toxicity. 3: Re-irradiation for local relapse converged on the use of partial breast irradiation after second breast conserving surgery. Hyperthermia aroused support but is not widely available. Further studies are required to finetune best practice, especially given the increasing use of re-irradiation.Copyright © 2023. Published by Elsevier B.V.
Àrees temàtiques: Saúde coletiva Oncology Odontología Medicina ii Medicina i Hematology Geriatrics and gerontology Ciências biológicas i Biotecnología
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
Adreça de correu electrònic de l'autor: meritxell.arenas@urv.cat
Identificador de l'autor: 0000-0003-0815-2570
Data d'alta del registre: 2024-08-03
Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
Enllaç font original: https://www.sciencedirect.com/science/article/pii/S1040842823001233?via%3Dihub
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
Referència a l'article segons font original: Critical Reviews In Oncology Hematology. 187 104035-104035
Referència de l'ítem segons les normes APA: Aristei C; Kaidar-Person O; Boersma L; Leonardi MC; Offersen B; Franco P; Arenas M; Bourgier C; Pfeffer R; Kouloulias V; Bölükbaşı Y; Meattini I; Cole (2023). The 2022 Assisi Think Tank Meeting: White paper on optimising radiation therapy for breast cancer. Critical Reviews In Oncology Hematology, 187(), 104035-104035. DOI: 10.1016/j.critrevonc.2023.104035
DOI de l'article: 10.1016/j.critrevonc.2023.104035
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2023
Tipus de publicació: Journal Publications